Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding. [electronic resource]
Producer: 20191212Description: 748-756 p. digitalISSN:- 1524-4539
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- adverse effects
- Anticoagulants -- adverse effects
- Dabigatran -- adverse effects
- Drug Substitution
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- Follow-Up Studies
- Gastrointestinal Hemorrhage -- epidemiology
- Humans
- Male
- Middle Aged
- Prospective Studies
- Risk Assessment
- United States -- epidemiology
- Venous Thromboembolism -- drug therapy
- Vitamin K -- antagonists & inhibitors
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.